A randomized controlled trial of Solcoseryl and DuoDerm in chronic sickle-cell ulcers
West Indian med. j
;
42(3): 121-3, Sept. 1993.
Article
Dans Anglais
| LILACS
| ID: lil-130582
ABSTRACT
A randomized controlled trial of Solcoseryl, DuoDerm and conventional conservative therapy with Eusol has been performed in 32 patients with homozygous sickle-cell (SS) disease. After 12 weeks' baseline observation, patients were randomized to one of three therapies and monitored for a further 12 weeks. Of 44 ulcerated legs, 20 received control treatment, 12 Solcoseryl and 12 DuoDerm. DuoDerm was generally unacceptable, and two-thirds of the patients defaulted from this treatment. Solcoseryl increased ulcer healing compared to the controls but the difference was not significant. Solcoseryl was well tolerated and may have a role in the treatment of chronic leg ulcers of sickle-cell disease.
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Actihaemyl
/
Colloïdes
/
Drépanocytose
/
Ulcère de la jambe
/
Pansements occlusifs
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Femelle
/
Humains
/
Mâle
Pays comme sujet:
Caraïbes anglaises
/
Jamaïque
langue:
Anglais
Texte intégral:
West Indian med. j
Thème du journal:
Médicament
Année:
1993
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS